The JAK2/STAT3 pathway has been shown to mediate resistance to tamoxifen in CD44+CD24−/low BCSC [125,126], and that the IL6/JAK1/STAT3/Oct4 pathway may be involved in the conversion of breast non-cancer stem cells to BCSC [127]. The gene discussed is STAT3; the disease is cancer.